Release Date: 07/11/14 10:33 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 192.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%